📰 Aldx News
Aldx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aldx. Real-time updates on events, politics, business and more.
May 18, 2024
StockNews.com upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a sell rating to a hold rating in a research report released on Tuesday morning. Several other equities analysts have also commented on the company. HC Wainwright reiterated a buy rating and issued a $10.00 target price on shares of Aldeyra Therapeutics in a […]
April 8, 2024
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) major shareholder Perceptive Advisors Llc acquired 37,712 shares of the firm’s stock in a transaction that occurred on Friday, April 5th. The shares were bought at an average price of $4.74 per share, with a total value of $178,754.88. Following the acquisition, the insider now directly owns […]
April 6, 2024
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) major shareholder Perceptive Advisors Llc acquired 8,374 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were bought at an average cost of $3.25 per share, for a total transaction of $27,215.50. Following the completion of the transaction, the insider now […]
March 13, 2024
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) insider Bruce Greenberg sold 13,201 shares of Aldeyra Therapeutics stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $3.41, for a total transaction of $45,015.41. Following the sale, the insider now directly owns 120,699 shares in the […]
December 19, 2023
By Denny Jacob Aldeyra Therapeutics shares rose 12% to $3.31 following news of positive topline results from a Phase 2 clinical trial of ADX-629, a treatment...
November 1, 2023
By Rob Curran Aldeyra Therapeutics shares rose after the development-stage biotech company struck a licensing deal with drug giant AbbVie on an eye-condition...
November 1, 2023
Health-care companies rose, but not by as much as the broad market, amid mixed earnings reports. Shares of drug-store chain and insurer CVS Health fell after...
October 20, 2023
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Free Report) major shareholder Perceptive Advisors Llc sold 2,450,000 shares of Aldeyra Therapeutics stock in a transaction on Monday, October 16th. The stock was sold at an average price of $1.60, for a total value of $3,920,000.00. Following the completion of the transaction, the insider now owns 8,900,085 shares […]
October 16, 2023
Aldeyra Therapeutics, Inc. (ALDX) shares are falling more than 58 percent on Monday morning trade after the company announced that the FDA, in a review related to its new drug application for Reproxalap for dry eye disease, opined that the data is not supporting the clinical relevance of the ocular signs to support dry eye indication.
October 16, 2023
Shares of Aldeyra Therapeutics Inc. plummeted 61.9% toward a 3 1/2-year low in very active morning trading Monday, enough to pace the Nasdaq’s decliners,...